News for Read Beyond News
After losing the approval for emergency use of COVID-19 vaccines, AstraZeneca has finally stopped efforts to sell its COVID-19 vaccine shots in the United States. AstraZeneca has now decided to withdraw its application for the COVID-19 vaccine Vaxzevria with the US FDA, said CEO Pascal Soriot during a press briefing. Because
Read More
The US Food and Drug Administration (FDA) approved AstraZeneca’s cancer drugs Imfinzi and Imjudo in combination with chemotherapy to treat patients with stage 4 non-small cell lung cancer. This approval is based on the phase 3 data published in September 2021. Imfinzi and Imjudo with chemotherapy have shown an overall 23
Read More
The US Food and Drug Administration’s (FDA) Pulmonary-Allergy Drugs Advisory Committee (PADAC) has recommended AstraZeneca’s PT027 for the treatment of asthma in people aged 18 years and older. The Committee has voted 9 to 8 for adolescents aged 12 to 17 years, and the data do not support a favourable
Read More
The European Commission (EC) approved Beyfortus, jointly developed by AstraZeneca and Sanofi, for the prevention of a common and highly contagious type of respiratory infection in infants. This long-acting therapy, which is also known as nirsevimab, was given marketing authorisation in the European Union (EU) for the prevention of disease from
Read More
The US Food and Drug Administration (FDA) of the United States, AstraZeneca’s Evusheld is proving ineffective against Omicron COVID-19 variants. Amid new reports, the antibody combination is ineffective against the latest subvariant of Omicron COVID-19 variants, including BA.4.6. The US FDA said that it can increase the risk of COVID-19 infection
Read More
The US Food and Drug Administration (FDA) has approved Enhertu of AstraZeneca and Daiichi Sankyo for the treatment of adult patients with metastatic HER2-low breast cancer, who have received a prior chemotherapy in the metastatic setting during six months of completing adjuvant chemotherapy. Enhertu is a specifically designed HER2-directed antibody drug
Read More
Pascal Soriot, head of AstraZeneca has been calling on the government for the purpose of providing access to the corona virus vaccine of AstraZeneca known as Evusheld and he said that, it has been a sad situation that, the United Kingdom has been one of the few developed nations, which
Read More
Huma Therapeutics Limited, a digital health technology company has announced partnership with AstraZeneca for the purpose of scaling the innovation of digital health. This partnership has been following the prior use cases have been executed between AstraZeneca and Huma has been reflecting a shared ambition for the purpose of improving
Read More
The pharmaceutical company ‘AstraZeneca’ said, the antibody-based cocktail of the company for the prevention and treatment of the novel corona virus had been showing to retain the neutralization activity against the Omicron corona virus variants that is including the highly contagious BA.2 sub variant of the Omicron in a study
Read More
The UK MHRA (Medicines and Healthcare products Regulatory Agency) has now granted the authorization to the Evusheld of AstraZeneca for the pre-exposure prophylaxis (PrEP) against the novel corona virus, and the Evusheld has been a cocktail of the two monoclonal long-acting antibodies, along with the cilgavimab and tixagevimab. The company ‘AstraZeneca’
Read More